Eicosanoid production by Candida parapsilosis and other pathogenic yeasts

References

• Smith WL. The eicosanoids and their biochemical mechanisms of action. Biochem J. 1989;259:315–324.
   PubMed Web of Science ®Google Scholar
• Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 2001;294:1871–1875.
   PubMed Web of Science ®Google Scholar
• Dennis EA, Norris PC. Eicosanoid storm in infection and inflammation. Nat Rev Immunol. 2015;15:511–523.
   PubMed Web of Science ®Google Scholar
• Buczynski MW, Dumlao DS, Dennis EA. Thematic review series: Proteomics. an integrated omics analysis of eicosanoid biology. J Lipid Res. 2009;50:1015–1038.
   PubMed Web of Science ®Google Scholar
• Vigor C, Bertrand-Michel J, Pinot E, et al. Non-enzymatic lipid oxidation products in biological systems: assessment of the metabolites from polyunsaturated fatty acids. J Chromatogr B Anal Technol Biomed Life Sci. 2014;964:65–78.
   PubMed Web of Science ®Google Scholar
• van Dyk MS, Kock JL, Coetzee DJ, et al. Isolation of a novel arachidonic acid metabolite 3-hydroxy-5,8,11,14-eicosatetraenoic acid (3-HETE) from the yeast Dipodascopsis uninucleata UOFs-Y128. FEBS Lett. 1991;283:195–198.
   PubMed Web of Science ®Google Scholar
• Deva R, Ciccoli R, Kock L, et al. Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis. FEMS Microbiol Lett. 2001;198:37–43.
   PubMed Web of Science ®Google Scholar
• Noverr MC, Phare SM, Toews GB, et al. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infect Immun. 2001;69:2957–2963.
   PubMed Web of Science ®Google Scholar
• Erb-Downward JR, Huffnagle GB. Cryptococcus neoformans produces authentic prostaglandin E2 without a cyclooxygenase. Eukaryot Cell. 2007;6:346–350.
   PubMedGoogle Scholar
• Erb-Downward JR, Noverr MC. Characterization of prostaglandin E2 production by Candida albicans. Infect Immun. 2007;75:3498–3505.
   PubMed Web of Science ®Google Scholar
• Noverr MC, Toews GB, Huffnagle GB. Production of prostaglandins and leukotrienes by pathogenic fungi. Infect Immun. 2002;70:400–402.
   PubMed Web of Science ®Google Scholar
• Haas-Stapleton EJ, Lu Y, Hong S, et al. Candida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1. PLoS One. 2007;2:e1316.
   PubMed Web of Science ®Google Scholar
• Noverr MC, Erb-Downward JR, Huffnagle GB. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev. 2003;16:517–533.
   PubMed Web of Science ®Google Scholar
• Shiraki Y, Ishibashi Y, Hiruma M, et al. Candida albicans abrogates the expression of interferon-gamma-inducible protein-10 in human keratinocytes. FEMS Immunol Med Microbiol. 2008;54:122–128.
   PubMed Web of Science ®Google Scholar
• Alem MAS, Douglas LJ. Prostaglandin production during growth of Candida albicans biofilms. J Med Microbiol. 2005;54:1001–1005.
   PubMed Web of Science ®Google Scholar
• Ells R, Kock JLF, Albertyn J, et al. Effect of inhibitors of arachidonic acid metabolism on prostaglandin E(2) production by Candida albicans and Candida dubliniensis biofilms. Med Microbiol Immunol. 2011;200:23–28.
   PubMed Web of Science ®Google Scholar
• Ells R, Kemp G, Albertyn J, et al. Phenothiazine is a potent inhibitor of prostaglandin E2 production by Candida albicans biofilms. FEMS Yeast Res. 2013;13:849–855.
   PubMed Web of Science ®Google Scholar
• Fourie R, Ells R, Swart CW, et al. Candida albicans and Pseudomonas aeruginosa Interaction, with Focus on the Role of Eicosanoids. Front Physiol. 2016;7:64.
   PubMed Web of Science ®Google Scholar
• Bordon AP, Dias-Melicio LA, Acorci MJ, et al. Prostaglandin E(2) production by high and low virulent strains of Paracoccidioides brasiliensis. Mycopathologia. 2007;163:129–135.
   PubMed Web of Science ®Google Scholar
• Biondo GA, Dias-Melicio LA, Bordon-Graciani AP, et al. Paracoccidioides brasiliensis uses endogenous and exogenous arachidonic acid for PGE x production. Mycopathologia. 2010;170:123–130.
   PubMed Web of Science ®Google Scholar
• Biondo GA, Dias-Melicio LA, Bordon-Graciani AP, et al. de Campos Soares AMV. Production of leukotriene B4 by Paracoccidioides brasiliensis. Yeast. 2012;29:201–208.
   PubMed Web of Science ®Google Scholar
• Ells R, Kock JL, Albertyn J, et al. Arachidonic acid metabolites in pathogenic yeasts. Lipids Health Dis. 2012;11:100.
   PubMed Web of Science ®Google Scholar
• Alem MAS, Douglas LJ. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother. 2004;48:41–47.
   PubMed Web of Science ®Google Scholar
• Erb-Downward JR, Noggle RM, Williamson PR, et al. The role of laccase in prostaglandin production by Cryptococcus neoformans. Mol Microbiol. 2008;68:1428–1437.
   PubMed Web of Science ®Google Scholar
• Noverr MC, Cox GM, Perfect JR, et al. Role of PLB1 in pulmonary inflammation and cryptococcal eicosanoid production. Infect Immun. 2003;71:1538–1547.
   PubMed Web of Science ®Google Scholar
• Harris SG, Padilla J, Koumas L, et al. Prostaglandins as modulators of immunity. Trends Immunol. 2002;23:144–150.
   PubMed Web of Science ®Google Scholar
• Suram S, Gangelhoff TA, Taylor PR, et al. Pathways regulating cytosolic phospholipase A2 activation and eicosanoid production in macrophages by Candida albicans. J Biol Chem. 2010;285:30676–30685.
   PubMed Web of Science ®Google Scholar
• Suram S, Brown GD, Ghosh M, et al. Regulation of cytosolic phospholipase A2 activation and cyclooxygenase 2 expression in macrophages by the β-glucan receptor. J Biol Chem. 2006;281:5506–5514.
   PubMed Web of Science ®Google Scholar
• Valdez PA, Vithayathil PJ, Janelsins BM, et al. Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells. Immunity. 2012;36:668–679.
   PubMed Web of Science ®Google Scholar
• Gagliardi MC, Teloni R, Mariotti S, et al. Endogenous PGE2 promotes the induction of human Th17 responses by fungal β-glucan. J Leukoc Biol. 2010;88:947–954.
   PubMed Web of Science ®Google Scholar
• Smeekens SP, van de Veerdonk FL, van der Meer JWM, et al. The Candida Th17 response is dependent on mannan- and β-glucan-induced prostaglandin E2. Int Immunol. 2010;22:889–895.
   PubMed Web of Science ®Google Scholar
• Noverr MC, Huffnagle GB. Regulation of Candida albicans morphogenesis by fatty acid metabolites. Infect Immun. 2004;72:6206–6210.
   PubMed Web of Science ®Google Scholar
• Tsitsigiannis DI, Keller NP. Oxylipins as developmental and host-fungal communication signals. Trends Microbiol. 2007;15:109–118.
   PubMed Web of Science ®Google Scholar
• Eck R, Hundt S, Hartl A, et al. A multicopper oxidase gene from Candida albicans: cloning, characterization and disruption. Microbiology. 1999;145(Pt 9):2415–2422.
   PubMed Web of Science ®Google Scholar
• Erb-Downward JR, Huffnagle GB. Role of oxylipins and other lipid mediators in fungal pathogenesis. Future Microbiol. 2006;1:219–227.
   PubMed Web of Science ®Google Scholar
• Brodhun F, Feussner I. Oxylipins in fungi. FEBS J. 2011;278:1047–1063.
   PubMed Web of Science ®Google Scholar
• Guinea J. Global trends in the distribution of Candida species causing candidemia. Clin Microbiol Infect. 2014;20(Suppl 6):5–10.
   Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133–163.
   PubMed Web of Science ®Google Scholar
• Quindos G. Epidemiology of candidaemia and invasive candidiasis. A changing face. Rev Iberoam Micol. 2014;31:42–48.
   PubMed Web of Science ®Google Scholar
• el-Mohandes AE, Johnson-Robbins L, Keiser JF, et al. Incidence of Candida parapsilosis colonization in an intensive care nursery population and its association with invasive fungal disease. Pediatr Infect Dis J. 1994;13:520–524.
   PubMed Web of Science ®Google Scholar
• Pammi M, Holland L, Butler G, et al. Candida parapsilosis is a significant neonatal pathogen: a systematic review and meta-analysis. Pediatr Infect Dis J. 2013;32:e206–e216.
   PubMed Web of Science ®Google Scholar
• Trofa D, Gacser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev. 2008;21:606–625.
   PubMed Web of Science ®Google Scholar
• Lupetti A, Tavanti A, Davini P, et al. Horizontal transmission of Candida parapsilosis candidemia in a neonatal intensive care unit. J Clin Microbiol. 2002;40:2363–2369.
   PubMed Web of Science ®Google Scholar
• Bonassoli LA, Bertoli M, Svidzinski TIE. High frequency of Candida parapsilosis on the hands of healthy hosts. J Hosp Infect. 2005;59:159–162.
   PubMed Web of Science ®Google Scholar
• Clerihew L, Lamagni TL, Brocklehurst P, et al. Candida parapsilosis infection in very low birthweight infants. Arch Dis Child Fetal Neonatal Ed. 2007;92:F127–F129.
   PubMed Web of Science ®Google Scholar
• Grózer Z, Tóth A, Tóth R, et al. Candida parapsilosis produces prostaglandins from exogenous arachidonic acid and OLE2 is not required for their synthesis. Virulence. 2015;6:85–92.
   PubMed Web of Science ®Google Scholar
• Chakraborty T, Thuer E, Heijink M, et al. Eicosanoid biosynthesis influences the virulence of Candida parapsilosis. Virulence. 2018;9:1019–1035.
   PubMed Web of Science ®Google Scholar
• Tsitsigiannis DI, Bok J-W, Andes D, et al. Aspergillus cyclooxygenase-like enzymes are associated with prostaglandin production and virulence. Infect Immun. 2005;73:4548–4559.
   PubMed Web of Science ®Google Scholar
• Kilunga Kubata B, Eguchi N, Urade Y, et al. Plasmodium falciparum produces prostaglandins that are pyrogenic, somnogenic, and immunosuppressive substances in humans. J Exp Med. 1998;188:1197–1202.
   PubMed Web of Science ®Google Scholar
• Kubata BK, Duszenko M, Kabututu Z, et al. Identification of a novel prostaglandin f(2alpha) synthase in Trypanosoma brucei. J Exp Med. 2000;192:1327–1338.
   PubMed Web of Science ®Google Scholar